Skip to main content
Free trial

Ask AI to review this stock

Copy the prompt to get recent events, historical reactions, and a short research brief.

Tell your AI:

Help me set up FinLab and analyze 6762 達亞. Please read: https://finlab.finance/en/setup?stock=6762

No install, open FinLab Studio

6762

達亞 Biotech & Healthcare As of 2026-07-29 Updated daily after market close

steady quality, premium valuation.

1 active signal
Revenue ≥20%
This page refreshes daily after the close. Add 達亞 to your watchlist to track signal changes on your next visit.
估值 14品質 40成長 61動能 73籌碼 21

Is 達亞 a buy? Fundamentals and valuation first

  • 獲利能力中上。營業利益率位居全市場第 52 百分位。最新一季 ROE 約 1.6%。

  • 估值偏貴。本益比落在全市場第 98 百分位，比多數個股貴。以自身歷史看，目前本益比約在第 97 百分位。

  • 外資近期偏賣。外資近 20 日買賣超約佔成交量 -4.3%（賣超）。

  • 營收高成長。最新月營收年增率約 21.8%，超過 20% 的成長門檻。

Chip flow

Bullish +0.79
BearishNeutralBullish

Single-sided accumulation, concentration rising — bullish

  • Single-sided accumulation, concentration rising — bullish
  • 元富-桃園 holds 45 lots
  • sellers have 6 lots left, ~20 sessions to clear

Window from 2026-01-17 · Price +6% · branches to 2026-06-11· TDCC to 2026-06-12

  • Largest holder 元富-桃園 has accumulated 45 lots since the start (sold 0%), holding.
  • Main distributor 富邦-仁愛 peaked at 19 lots, has sold 89%, 2 left, ~1 sessions to clear at the recent pace.
  • TDCC big holders (absolute) >1000-lot holders +3.67pp, mid holders +0, retail -1.35pp — concentration shifting upward.
  • Foreign hedge-desk net short Net short -3 lots (inferred from branch profile, mostly hedging — not necessarily bearish, not case-confirmed).
Branch inventory reconstruction
Accumulating holders Branches that accumulated shares during the window and still hold positive inventory; they are the absorbing side.
Distributing sellers Branches that built inventory earlier and have been selling it down; the remaining number estimates what has not cleared.
Net-short desks Trading-desk branches with negative inventory or net selling, often hedge, offsetting, or short-term flow. It is not automatically a bearish view.
Accumulating
元富-桃園福邦證券永豐金證券富邦-台北凱基-台北華南永昌-民權
Distributing
富邦-仁愛兆豐-天母群益金鼎-新莊元大-台中元大-鑫永和凱基-高美館
Desks
own scale
元大-竹北華南永昌大昌-桃園台新-高雄
Price Accumulating & Distributing share one scale (comparable); Desks is independent. Zero is the baseline
Branch details Unit: lots

Accumulating

  • 元富-桃園 +45
    sold 0%
  • 福邦證券 +43
    sold 0%
  • 永豐金證券 +41
    sold 7%
  • 富邦-台北 +39
    sold 0%· still adding
  • 凱基-台北 +27
    sold 10%
  • 華南永昌-民權 +13
    sold 0%· still adding

Distributing

  • 富邦-仁愛 2 left
    sold 89%· ~1 sessions to clear
  • 兆豐-天母 2 left
    sold 50%· ~10 sessions to clear
  • 群益金鼎-新莊 2 left
    sold 50%· paused recently
  • 元大-台中 2 left
    sold 33%· ~20 sessions to clear
  • 元大-鑫永和 1 left
    sold 50%· paused recently
  • 凱基-高美館 1 left
    sold 50%· paused recently

Desks

  • 元大-竹北 -32
    unclassified
  • 華南永昌 -25
    unclassified
  • 大昌-桃園 -23
    unclassified
  • 台新-高雄 -18
    unclassified
Still selling 6 lots ~20 sessions to bottom at most
Recent buy/sell force +50 absorbed / -18 sold buyers slightly ahead
TDCC big holders · absolute-holding cross-check
>1000-lot holder share Retail (<400 lots) share Price (right axis)

Direction matches: big-holder share rose while retail share fell.

Describes chip flow, not investment advice. Branch data discloses only high-volume branches with ~1-day lag; TDCC is weekly. Inventory is a relative reconstruction from the window start, not absolute holdings.

Historical evidence

目前正在發生的訊號

以下訊號在最近一筆資料中成立，附這檔股票自身歷史上每次出現後的前瞻報酬統計

月營收年增率 ≥ 20%（公告截止日起算）

Active · now 21.79%

單月營收年增率達 20% 以上；事件日為公告截止日後第一個交易日，避免提前用到未公告資訊

37 historical occurrences (since 2020-12-18)
Average forward return after 月營收年增率 ≥ 20%（公告截止日起算）。20-day: Win 56%, Sample 25, Median +0.44%, Excess -0.69%, Beat mkt rate 40%；60-day: Win 56%, Sample 25, Median +2.45%, Excess -4.07%, Beat mkt rate 36%；120-day: Win 48%, Sample 25, Median -0.8%, Excess -14.89%, Beat mkt rate 20%

120 days after: historical avg -1.79%

20-day +1.2%
60-day +1.71%
120-day -1.79%
20-day
60-day
120-day
Win
56%
56%
48%
Sample
25
25
25
Median
+0.44%
+2.45%
-0.8%
Excess
-0.69%
-4.07%
-14.89%
Beat mkt rate
40%
36%
20%

Over 25 occurrences, 120-day forward avg declined 1.79%, lagged the market by 14.89 pts; win rate 48%.

估值位階與後續報酬

把這檔股票每天的本益比，換算成「截至當天為止的自身歷史百分位」，再看不同估值位階之後 240 個交易日的還原股價報酬。

PE percentile bandSample days240-day avg returnMedianWin rateAvg excess (vs index)
0-20 0Insufficient data
20-40 0Insufficient data
40-60 0Insufficient data
60-80 23Insufficient data
80-100 You are here287-1.4% -4.2% 46.7% -21.6%

百分位以當天為止的自身歷史滾動計算（expanding），不含未來資訊；前瞻報酬為還原股價 240 交易日。樣本日重疊，僅供分布參考。

目前本益比約 352.0，落在自身歷史第 97.0 百分位，屬於 80-100 區間。

估值 × 動能的歷史對照

把自身歷史的每一天，依估值位階（本益比自身歷史三分位）與 60 日動能方向分成六格，看各情境之後 120 個交易日的還原股價報酬。

Valuation
Momentum
便宜
中等
昂貴
向上
Insufficient data
(0d)
Insufficient data
(0d)
Now
-1.7%
Win rate 47.1% Excess -11.1%
189d
向下
Insufficient data
(0d)
Insufficient data
(0d)
+2.4%
Win rate 39.8% Excess -16.9%
181d

Currently in “昂貴（自身歷史後 1/3） × 60 日動能向上”: across 189 historical days, 120-day forward avg declined 1.7%, win rate 47.1%, lagged the market by 11.1%.

Days = trading days in this bucket; returns use adjusted prices, ex-costs. 60-day momentum: direction of this stock's price over the past 60 trading days.

這個訊號在全市場是否站得住腳

「月營收年增率 ≥ 20%」過去 243 個月，每月平均約 404 檔個股符合條件；這些個股之後 60 個交易日的還原股價報酬，等權平均為 6.99%，平均贏過大盤 2.32 個百分點，在 64.2% 的月份中跑贏發行量加權股價報酬指數。

每月對全市場符合訊號的股票取等權平均前瞻 60 日還原報酬，再對月份平均；超額相對發行量加權股價報酬指數

目前未成立的訊號（歷史統計供參）

這些訊號現在沒有發生，列出歷史樣本以供對照

股價創 252 日新高（突破日）

Pending

還原股價首次站上過去 252 個交易日最高；20 日內重複觸發只計一次

外資連續買超滿 5 個交易日

Pending

外資（不含自營商）買賣超連續 5 日為正，事件日為第 5 日；20 日內重複觸發只計一次

9 times historically; 60-day forward avg -2.21%, win rate 66.7%, beating the market by -6.38 pts on average.

方法與限制

  • 所有報酬以還原股價（etl:adj_close）計算，已還原除權息與股票分割。
  • 超額報酬以發行量加權股價報酬指數（含息）為基準。
  • 估值位階與分位統計以「截至當天為止的自身歷史」滾動計算，不使用未來資訊。
  • 營收訊號的事件日對齊到公告截止日後第一個交易日，避免提前用到尚未公開的資訊。
  • 事件樣本之間日期可能重疊，統計僅描述歷史分布，樣本數較少時參考價值有限。

本頁內容為歷史資料統計與教育用途，不構成投資建議。投資一定有風險，過去績效不代表未來表現，交易前請自行評估並承擔風險。